Novalar Pharmaceuticals has entered into an agreement with H.A. Systems Dental Imports to distribute OraVerse in Israel and the Palestinian Territories.
Under the agreement, H.A. Systems will file the necessary documents for regulatory clearance of OraVerse -- Novalar's proprietary anesthesia-reversal agent -- with the Israel Ministry of Health. Upon granting of the clearance, H.A. Systems will have exclusive rights to promote and distribute OraVerse to dentists in the territory through the company's established dental franchise and sales force, Novalar said in a press release.
Copyright © 2010 DrBicuspid.com
